mto-yug.ru


AXSM STOCK BUY OR SELL

Invest in. Shares Dollars ; Current$ ; Target %$ ; Axsome Therapeutics Stock Rating. What analysts recommend for AXSM stock, on a scale from 1(buy). Overall, Axsome Therapeutics Inc stock has a Growth Grade of F, Momentum Grade of A Earnings Estimate Revisions Grade of C. Whether or not you should buy. If you are looking for stocks with good return, Axsome Therapeutics Inc can be a profitable investment option. Axsome Therapeutics Inc quote is equal to %. Analyst Ratings. Sell; Under; Hold; Over; Buy. Number of Ratings 15 Full Ratings. Recent News. MarketWatch. Dow Jones. Axsome's stock falls after. 20 Day Moving Average, Sell ; 20 - 50 Day MACD Oscillator, Buy ; 20 - Day MACD Oscillator, Buy ; 20 - Day MACD Oscillator, Buy ; 20 - Day Average Volume.

Buying or selling a stock that's not traded in your local currency? Don't let the currency conversion trip you up. Convert Axsome Therapeutics Inc stocks or. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst Month AXSM price targets. Created with Highcharts Zacks' proprietary data indicates that Axsome Therapeutics, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the AXSM shares. According to our Axsome Therapeutics stock prediction for , AXSM stock will be priced at $ in This forecast is based on the stock's average. If you are looking for stocks with good return, Axsome Therapeutics Inc can be a profitable investment option. Axsome Therapeutics Inc quote is equal to If all goes right, this stock could triple. Overall, the market is getting more interested in biotechs, and two analysts just started coverage (buy and. Is Axsome Therapeutics Stock Undervalued? The current Axsome Therapeutics [AXSM] share price is $ The Score for AXSM is 40, which is 20% below its. Stock Price Target ; High, $ ; Low, $ ; Average, $ ; Current Price, $ According to 10 analysts, the average rating for AXSM stock is "Strong Buy." The month stock price forecast is $, which is an increase of % from.

AXSM Price Target ; High · $ ; Low · $ ; Average · $ The consensus among 8 Wall Street analysts covering (NASDAQ: AXSM) stock is to Strong Buy AXSM stock. Out of 8 analysts, 6 (75%) are recommending AXSM as a. Axsome Therapeutics Stock Smart Score ; Analyst Consensus. Strong Buy. Average Price Target: $ (% Upside) ; Blogger Sentiment. Bullish. AXSM Sentiment. Price. 5-Star Price. Economic Moat. Capital Allocation: —. Is it the right time to buy, sell, or hold? Start a free trial of Morningstar Investor to unlock. According to the issued ratings of 11 analysts in the last year, the consensus rating for Axsome Therapeutics stock is Moderate Buy based on the current 2. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst Month AXSM price targets. Created with Highcharts The average analyst rating for AXSM stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in. Based on short-term price targets offered by 14 analysts, the average price target for Axsome Therapeutics comes to $ The forecasts range from a low of. Execute Axsome Therapeutics Buy or Sell Advice ; Investor Sentiment. Interested ; Analyst Consensus. Strong Buy ; Financial Strenth (F Score). Poor ; Financial.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axsome Therapeutics in the last year. There are currently 2 hold ratings and 9 buy. If all goes right, this stock could triple. Overall, the market is getting more interested in biotechs, and two analysts just started coverage (buy and. 15 analyst ratings ; buy 87% ; hold 13% ; sell 0%. Current Technical Analysis and interactive chart for $AXSM stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.

nebulas com | paydex

11 12 13 14 15


Copyright 2013-2024 Privice Policy Contacts SiteMap RSS